Publication list

Breast Surgery Division

1.

Shigeoka Y, Itoh K, Igarashi T, Ishizawa K, Saeki T, Fujii H, Minami H, Imoto S, Sasaki Y. Clinical effect of irinotecan in advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxelcontaining egimens. Jpn J Clin Oncol 2001;31:370-374.

2.

Fukui S, Kugaya A, Kamiya M, Koike M, Okamura H, Nakanishi T, Wenner M, Imoto S, Kanagawa K, Uchitomi Y.Participation in psychosocial group intervention among Japanese women with primary breast cancer and its associated factors. Psychooncology 2001;10:419-427.

3.

Hasebe T, Sasaki S, Imoto S, Ochiai A. Highly proliferative fibroblasts forming fibrotic focus govern metastasis of invasive ductal carcinoma of the breast. Mod Pathol 2001;14:325-337.
4. Akechi T, Okuyama T, Imoto S, Yamawaki S, Uchitomi Y. Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast Cancer Res Treat 2001;65:195-202.
Colorectal (Pelvic) Surgery Division

1.

Hasebe T, Sasaki S, Sugitoh M, Ono M, Saito M, Ochiai A. Highly proliferative intratumoral fibroblasts and a high proliferative microvessel index are significant predictors of tumor metastasis in T3 ulcerative-type colorectal cancer. Hum Pathol 2001;4:401-409.
2. Nakamura T, Kinoshita T, Konishi M, Nakagouri T, Inoue K, Oda T, Itou M, Sugitou M, Ono M, Saito N. Function preserving partial resection for early cancer of the remnant stomach. In: Brennan MF editor. 4th International Gastric Cancer Congress. Bologna: Monduzzi Editore. 2001;971-974.
3. Ito M, Shichijo S, Tsuda N, Harashima H, Itoh K. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res 2001;61:2038-2046.
4. Imai N, Harashima N, Ito M, Miyagi Y, Harada M, Yamada A, Itoh K. Identification of Lck-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with distant metastases. Int J Cancer 2001;94:237-242.
5. Tamura M, Nishizaka Y, Ito M, Haeashima N, Harada M, Shichijo S, Itoh K. Identification of cyclophilin B-derived peptides capable of inducing histocompatibility leukocyte antigen-A2-restricted and tumor-specific cytotoxic T lymphocytes. Jpn J Cancer Res 2001;92:762-767.
6. Takiguchi N, Saito N, Nunomura M, Kouda K, Oda K, Furutyama N, Nakajima N. Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol 2001;47:11-14.
7. Koda K, Glassy MC, McKnight ME, Yasutomi J, Saito N, Dan M, Nakajima N. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1. Anticancer Res 2001;21:621-627.
Diagnostic Radiology Division
1. Hong J-S, Kaneko T, Sekiguchi R, Park K-H. Automatic liver tumor detection from CT. IEICE Transactions on Information and Systems 2001:E84-D(6):741-748.
2. Sekiguchi R, Satake M. Breast Ultrasound: Advances in imaging with tissue harmonic imaging. The Radiologist 2001;8:213-220.
Digestive Endoscopy and Gastrointestinal Oncology Division
1. Arao J, Sano Y, Fujii T, Kato S, Fu KI, Yoshino T, Ochiai A, Fujimori T, Yoshida S. Cyclooxygenase-2 is overexpressed in serrated adenoma of the colorectum. Dis Colon Rectum 2001;44:1319-1323.
2. Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S. New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 2001;33:221-226.
3. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001;48:225-229.
4. Kato S, Fujii T, Koba I, Sano Y, Fu KI, Parra-Blanco A, Tajiri H, Yoshida S, Rembacken B. Assessment of colorectal lesions using magnifying colonoscopy and mucosal dye spraying: can significant lesions be distinguished? Endoscopy 2001;33:306-310.
5. Tajiri H, Ohtsu A, Boku N, Muto M, Chin K, Matsumoto S, Yoshida S. Routine endoscopy using electronic endoscopes for gastric cancer diagnosis: retrospective study of inconsistencies between endoscopic and biopsy diagnoses. Cancer Detect Prev 2001;25:166-173.
6. Nara K, Nagashima F, Yasui A. Highly elevated ultraviolet-induced mutation frequency in isolated Chinese hamster cell lines defective in nucleotide excision repair and mismatch repair proteins. Cancer Res 2001;61:50-52.
7. Fu KI, Fujii T, Kato S, Sano Y, Koba I, Mera K, Saito H, Yoshino T, Sugito M, Yoshida S. A new endoscopic tattooing technique for identifying the location of colonic lesions during laparoscopic surgery: a comparison with the conventional technique. Endoscopy 2001;33:687-691.
8. Boku N, Ohtsu A, Nagashima F, Muto M, Shinkai T, Yoshida S. Retrospective study of hyponatremia in gastric cancer patients treated with a combination chemotherapy of 5-fluorouracil and cisplatin: a possible warning sign of severe hematological toxicities? Jpn J Clin Oncol 2001;31:382-387.
9. Miyamoto S, Furuse J, Maru Y, Tajiri H, Muto M, Yoshino M. Duodenal tuberculosis with a choledocho-duodenal fistula. J Gastroenterol Hepatol 2001;16:235-238.
10. Miyamoto S, Boku N, Fujii T, Ohtsu A, Matsumoto S, Tajiri H, Yoshida S, Arai T, Ono M, Hasebe T, Ochiai A. Macroscopic typing with wall stricture sign may reflect tumor behaviors of advanced colorectal cancers. J Gastroenterol 2001;36:158-165.
11. Miyamoto S, Ochiai A, Boku N, Ohtsu A, Tahara M, Yoshida S, Okabe H, Takechi T, Fukushima M. Discrepancies between the gene expression, protein expression, and enzyme activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjancent normal mucosa. Int J Oncol 2001;18:705-713.
12. Miyamoto S, Ochiai A, Boku N, Ohtsu A, Tahara M, Yoshida S, Okabe H, Takechi T, Fukushima M. Discrepancies between the gene expression, protein expression, and enzymatic activity of thymidylate synthase and dihydropyrimidine dehydrogenase in human gastrointestinal cancers and adjacent normal mucosa. Int J Oncol 2001;18:705-713.
13. Muto M, Ohtsu A, Miyata Y, Shioyama Y, Boku N, Yoshida S. Self-expandable metallic stents for patients with recurrent esophageal carcinoma after failure of primary chemoradiotherapy. Jpn J Clin Oncol 2001;31:270-274.
14. Yamada Y, Shirao K, Ohtsu A, Boku N, Hyodo I, Saitoh H, Miyata Y, Taguchi T. Phase II trial of paclitaxel by threehour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Ann Oncol 2001;12:1133-1137.
15. Yoshida M, Boku N, Ohtsu A, Muto M, Nagashima F, Yoshida S. Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: efficacy and feasibility in clinical practice. Gastric Cancer 2001;4:144-149.
16. Hironaka S, Boku N, Ohtsu A, Ochiai A. Yoshida S. A case report: endoscopic mucosal resection for early adenocarcinoma arising in Barrettsi esophagus. Dig Endosc 2001;13:104-107.
17. Naylor GM, Fujii T, Ishii H, Kato S, Sano Y, Yoshida S. A 0.8-mm depressed adenoma of the colon with high-grade dysplasia. Endoscopy 2001;33:891-893.
18. Kondo H, Fukuda H, Ono H, Gotoda T, Saito D, Kozu T, Shirao K, Yamaguchi H, Yoshida S. Sodium thiosulfate solution spray for relieaf of irritation caused by Lugolis stain in chromoendoscopy. Gastrointest Endosc 2001;53:199-202.
19. Ishikura S, Ohtsu A. Place of Radiotherapy and chemoradiotherapy for superficial esophageal carcinoma. In: Yoshimura H et al., editors. Bronchology and Bronchoesophagology: State of the Art. Proceedings of the 11th World Congress for Bronchology (WCB) & the 11th World Congress for Bronchoesophagology (WCBE), held in Yokohama, Japan on the 7th-10th June, 2000, Amsterdam: Elsevier. 2001;193-196.
20. Ikeda N, Shimada Y, Ohtsu A, Boku N, Tsuji Y, Saito H, Koizumi W, Iwase H, Yoshida S, Fukuda H. A phase II study of doxifluridine in elderly patients with advanced gastric cancer: Japan Clinical Oncology Group (JCOG9410) Jpn J Clin Oncol (in press)
21. Sano Y. Analysis of K-ras codon 12 mutatons and p53 overexpression in colorectal nodule-aggregating tumors. J Gastroenterol Hepatol (in press)
22. Sano Y, Maeda N. Adenocarcinoma in serrated adenoma. Jpn J Clin Oncol (in press)
23. Tonooka T, Sano Y, Fujii T, Kato S, Fu KI, Yoshino T, Hironaka S, Ochiai A, Yoshida S. Adenocarcinoma in solitary large hyperplastic polyp diagnosed by magnifying colonoscope: report of a case. Dis Colon Rectum (in press)
24. Takahashi S, Kinoshita T, Konishi M, Nakagohri T, Inoue K, Ono M, Sugito M, Ohtsu A, Boku N. Phase II study of sequential high-dose methotraxate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer. Jpn J Clin Oncol (in press)
25. Tahara M, Ohtsu A, Boku N, Nagashima F, Muto M, Sano Y, Yoshida M, Mera K, Hironaka S, Tajiri H, Yoshida S.Sequential methotraxate and 5-fluorouracil therapy for gastric cancer patients with peritoneal dissemination: a retrospective study. Gastric Cancer (in press)
26. Hironaka S, Hasebe T, Kamijo T, Ohtsu A, Boku N, Yoshida S, Saitoh H, Ochiai A. Biopsy specimen microvessel density is a useful prognostic marker in patients with t(2-4)m(0) esophageal cancer treated with chemoradiotherapy. Clin Cancer Res (in press)
27. Miyamoto S, Muto M, Hamamoto Y, Boku N, Ohtsu A, Baba S, Yoshida M, Ohkuwa M, Hosokawa K, Tajiri H, Yoshida S. A new technique for endoscopic mucosal resection using an insulated-tip diathermic knife improves the completeness of resection of intramural gastric neoplasm. Gastrointest Endosc (in press)
Gastric Surgery Division
1. Kinoshita T, Konishi M, Nakagouri T, Inoue K, Oda T, Sugitou M. Result of Resection of hepatic metastases from gastric cancer. In: Brennan MF editor. 4th International Gastric Cancer Congress. Bologna: Monduzzi Editore. 2001;363-366.
2. Nakamura T, Kinoshita T, Konishi M, Nakagouri T, Inoue K, Oda T, Itou M, Sugitou M, Ono M, Saito N. partial resection for early cancer of the remnant stomach. In: Brennan MF editor. 4th International Gastric Cancer Congress. Bologna: Monduzzi Editore. 2001;971-974.
Head & Neck Surgery Division
1. Kimata Y, Uchiyama K, Sakuraba M, Ebihara S, Hayashi R, Asakage T, Nakatsuka T, Harii K. Deep circumflex iliacperforator flap with iliac crest for mandibular reconstruction. Br J Plast Reconstr Surg 2001;54:487-490.
2. Takushima A, Harii K, Asato H, Nakatsuka T, Kimata Y. Mandibular reconstruction using microvascular free flaps: a statistical analysis of 178 cases. Plast Reconstr Surg 2001;108:1555-1563.
3. Kimata Y, Uchiyama K, Sakuraba M, Ebihara S, Hayashi R, Haneda T, Onitsuka T, Asakage T, Nakatsuka T, Harii K. Velopharyngeal function after microsurgical reconstruction of lateral and superior oropharyngeal defects. Laryngoscope (in press)
4. Uchiyama K, Kimata Y, Sakuraba M, Ebihara S. Evaluating the donor site after harvesting of free jejunum. Head Neck (in press)
5. Uchiyama K, Kimata Y, Sakuraba M, Ebihara S. Appearance and histological analysis of intraoral skin flaps. Plast Reconstr Surg (in press)
Hepatobiliary & Pancreatic Oncology and Surgery Division
1. Furuse J, Maru Y, Yoshino M, Mera K, Sumi H, Tajiri H, Satake M, Onaya H, Ishikura S, Ogino T, Kawashima M,Ikeda H. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: results from a pilot study. Hepatogastroenterology 2001; 48:208-211.
2. Furuse J, Maru Y, Mera K, Sumi H, Yoshino M, Yokoyama Y, Hashimoto H, Ejiri A. Visualization of blood flow in hepatic vessels and hepatocellular carcinoma using B-Flow sonography. J Clin Ultrasound 2001;29:1-6.
3. Tanizaki H, Furuse J, Yoshino M, Ogino T, Ishikura S, Satake M, Hasebe T. Combination radiotherapy for hepatocelluiar carcinoma with intraductal tumor thrombus: A case report. Eur J Radiol 2001;38:213-218.
4. Miyamoto S, Furuse J, Maru Y, Muto M, Tajiri H, Yoshino M. Duodenal tuberculosis with a choledocho-duodenal fistula. J Gastroenterol Hepatol 2001;16:235-238.
5. Okada S, Ueno H, Okusaka T, Ikeda M, Furuse J, Maru Y. Phase I trial of gemcitabine in patients with advanced pancreatic cancer. Jpn J Clin Oncol 2001;31:7-12.
6. Abe T, Furuse J, Yoshino M, Kinoshita T, Konishi M, Inoue K, Hasebe T. Clinical characteristics of hepatocellular carcinoma with a high degree of lymph nodes metastases at the onset. Am J Clin Oncol (in press)
7. Tamai F, Furuse J, Maru Y, Yoshino M, Kinoshita T. Intrahepatic arterial pseudoaneurysm: a complication after radio-frequency ablation therapy for hepatocellular carcinoma. Eur J Radiol (in press)
8. Takahashi S, Hasebe T, Oda T, Sasaki S, Kinoshita T, Konishi M, Ueda T, Ochiai T, Ochiai A. Extra-tumor perineural invasion predicts postoperative development of peritoneal dissemination in pancreatic ductal adenocarcinoma. Anticancer Research 2001;21:1407-1412.
9. Izuishi K, Nakagohri T, Konishi M, Inoue K, Tajiri H, Kinoshita T. Spatial assessment by magnetic resonance cholangiopancreatography for preoperative imaging in partial pancreatic head resection. Am J Surg 2001;182:188-191.
10. Takahashi S, Oda T, Hasebe T, Sasaki S, Kinoshita T, Konishi M, Ueda T, Nakahashi C, Ochiai T, Ochiai A. Overexpression of Sialy Lewis x Antigen associated formation of extra-tumoral venous invasion and predicts postoperative development of massive hepatic metastasis in cases with pancreatic ductal adenocarcinoma. Pathobiology (in press)
11. Konishi M, Ryu M, Kinoshita T, Inoue K. Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 2001;48:1421-1424.
12. Nakagohri T, Asano T, Kenmochi T, Urashima T, Ochiai T. Long-term surgical outcome of noninvasive and minimally invasive intraductal papillary mucinous adenocarcinoma of the pancreas. World J Surg (in press)
13. Konishi M, Kinoshita T, Nakagohri T, Inoue K, Oda T, Takahashi S. Prognostic value of cytologic examination ofperitoneal washings in pancreatic cancer. Arch Surg (in press)
Oncology/Hematology Division
1. Minami H, Sasaki Y, Watanabe T, Ogawa M. Pharmacodynamic modeling of the entire time course of leukopenia after a 3-hour infusion of paclitaxel. Jpn J Cancer Res 2001;92:220-230.
2. Minami H, Ohtsu T, Fujii H, Igarashi T, Itoh K, Uchiyama-Kokubu N, Aizawa T, Watanabe T, Uda Y, Tanigawara Y, Sasaki Y. Phase I study of intravenous PSC-833 and doxorubucin: Reversal of multidrug resistance. Jpn J Cancer Res 2001;92:231-238.
3. Minami H, Fujii H, Igarashi T, Itoh K, Tamanoi K, Oguma T, Sasaki Y. Phase I and pharmacological study of a new camptothecin derivertive, exatecan metylate (DX-891f), infused over 30 minutes every three weeks. Clin Cancer Res 2001;7:3056-3064.
4. Sumi H, Itoh K, Onozawa Y, Shigeoka Y, Kodama K, Ishizawa K, Fujii H, Minami H, Igarashi T, Sasaki Y. Treatable subsets in cancer of unknown primary origin Jpn J Cancer Res 2001:92:704-709.
5. Miya T, Goya T, Fujii H, Ohtsu T, Itoh K, Igarashi T, Minami H, Sasaki Y. Factors affecting the pharmacokinetics of CPT-11: The body mass index, age and sex are independent predictors of pharmacokinetic parameters of CPT-11. Investigational New Drugs 2001;19:61-67.
6. Shigeoka Y, Itoh K, Igarashi T, Ishizawa K, Saeki T, Fujii H, Minami H, Imoto S, Sasaki Y. Clinical effect of irinotecan for advanced and metastatic breast cancer patients previously treated with doxorubicin- and docetaxelcontaining regimens. Jpn J Clin Oncol 2001;31:370-374.
7. Igarashi T, Ohtsu T, Fujii H, Sasaki Y, Morishima Y, Ogura M, Kagami Y, Kinoshita T, Kasai M, Kiyama Y, Kobayashi Y, Tobinai K. IDEC-C2B8 Study Group re-treatment of relapsed indolent B-cell lymphoma with rituximab. Int J Hematol 2001;73:213-221.
Palliative Care and Psychiatric Service
1. Akechi T, Nakano T, Okamura H, Ueda S, Akizuki N, Nakanishi T, Yoshikawa E, Matsuki H, Hirabayashi E, Uchitomi Y. Psychiatric disorders in cancer patients; descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Jpn J Clin Oncol 2001;31:188-194.
2. Akechi T, Okamura H, Nishiwaki Y, Uchitomi Y. Psychiatric disorders and associated and predictive factors in atients with unresectable nonsmall cell lung carcinoma; a longitudinal study. Cancer 2001;92:2609-2622.
3. Akechi T, Okamura H, Yamawaki S, Uchitomi Y. Why do some cancer patients with depression desire an early death and others do not? Psychosomatics 2001;42:141-145.
4. Akechi T, Okuyama T, Imoto S, Yamawaki S, Uchitomi Y. Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast Cancer Res Treat 2001;65:195-202.
5. Murakami Y, Gondo N, Okamura H, Akechi T, Uchitomi Y. Guilt from negative genetic test findings. Am J Psychiatry 2001;158:1929.
6. Okano Y, Okamura H, Watanabe T, Narabayashi M, Katsumata N, Ando M, Adachi I, Kazuma K, Akechi T, Uchitomi Y. Mental adjustment to first recurrence and correlated factors in patients with breast cancer. Breast Cancer Res Treat 2001;67:255-262.
7. Okuyama T, Tanaka K, Akechi T, Kugaya A, Okamura H, Nishiwaki Y, Hosaka T, Uchitomi Y. Fatigue in ambulatory patients with advanced lung cancer; prevalence, correlated factors, and screening. J Pain Symptom Manage 2001;22:554-564
8. Uchitomi Y, Kugaya A, Akechi T, Nakano T, Wenner M, Okamura H, Takebayashi M, Kagaya A, Saeki T, Yamawaki S. Three sets of diagnostic criteria for major depression and correlations with serotonin-induced platelet calcium mobilization in cancer patients. Psychopharmacology 2001;153:244-248.
9. Uchitomi Y, Mikami I, Kugaya A, Nakano T, Okuyama T, Akechi T, Okamura H. Physician support and patient psychological responses after surgery for nonsmall cell lung carcinoma; a prospective observational study. Cancer 2001;92:1926-1935.
10. Akizuki N, Okamura H, Akechi T, Nakano T, Yoshikawa E, Nakanishi T, Uchitomi Y. Clinical experience of the pharmacological treatment algorithm for major depression in advanced cancer patients; a preliminary study. Int J Psychiatry Clin Prac (in press)
11. Sugawara Y, Akechi T, Shima Y, Okuyama T, Akizuki N, Nakano T, Uchitomi Y. The Efficacy of methylphenidate for fatigue in advanced cancer patients; a preliminary study. Palliative Med (in press)
12. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage (in press)
13. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Factors correlated with dyspnea in advanced lung cancer patients; organic causes and what else? J Pain Symptom Manage (in press)
14. Tanaka K, Akechi T, Okuyama T, Nishiwaki Y, Uchitomi Y. Impact of dyspnea, pain and fatigue on daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage (in press)
Plastic & Reconstructive Surgery Division  
1. Kimata Y, Uchiyama K, Sakuraba M, Ebihara S, Hayashi R, Asakage T, Nakatsuka T, Harii K. Deep circumflex iliac perforator flap with iliac crest for mandibular reconstruction. Br J Plast Reconstr Surg 2001;54:487-490.
2. Takushima A, Harii K, Asato H, Nakatsuka T, Kimata Y. Mandibular reconstruction using microvascular free flaps: a statistical analysis of 178 cases. Plast Reconstr Surg 2001;108:1555-1563.
3. Kimata Y, Uchiyama K, Sakuraba M, Ebihara S, Hayashi R, Haneda T, Onitsuka T, Asakage T, Nakatsuka T, Harii K. Velopharyngeal function after microsurgical reconstruction of lateral and superior oropharyngeal defects. Laryngoscope (in press)
4. Uchiyama K, Kimata Y, Sakuraba M, Ebihara S. Evaluating the donor site after harvesting of free jejunum. Head Neck (in press)
5. Uchiyama K, Kimata Y, Sakuraba M, Ebihara S. Appearance and histological analysis of intraoral skin flaps. Plast Reconstr Surg (in press)
Radiation Oncology Division
1. Ikeda H. Editorial: Structure of radiotherapy in Japan. Jpn J Clin Oncol 2001;31:133-134.
2. Japan Lymphoma Radiation Therapy Group: Shikama N, Ikeda H, Nakamura S, Oguchi M, Isobe K, Hirota S, Hasegawa M, Nakamura K, Sasai K, Hayabuchi N. Localized aggressive non-Hodgkinis lymphoma of the nasal cavity: a survey by the Japan Lymphoma Radiation Therapy Group. Int J Radiat Oncol Biol Phys 2001;51:1228-1233.
3. Ando K, Furusawa Y, Suzuki M, Nojima K, Majima H, Koike S, Aoki M, Shimizu W, Futami Y, Ogino T, Murayama S, Ikeda H. Relative biological effectiveness of the 235 MeV proton beams at the National Cancer Center Hospital East. Jpn J Radiat Res 2001;42:79-89.
4. Goto K, Kodama T, Sekine I, Kakinuma R, Kubot K, Hojo F, Matsumoto T, Ohmatsu H, Ikeda H, Ando M,Nishiwaki Y. Serum levels of KL-6 are useful biomarkers for severe biomarkers for severe radiation pneumonitis.Lung Cancer 2001;34:141-148.
5. Ito Y, Ogino T, Ishikura S, Kawashima M, Nihei K, Murayama S, Ikeda H. Four-dimensional radiotherapy treatmentplanningfor liver tumors and evaluation of its dose distributions. Int J Radiat Oncol Biol Phys 2001;51(S1):209.
6. Ito Y, Kamijo T, Yokose T, Kawashima M, Ogino T, Ikeda H, Hayashi R, Sasaki S, Ochiai A. Microvessel density predicts the radiosensitivity of metastatic head and neck squamous cell carcinoma in cervical lymph nodes. Int J Oncol 2001;19:1127-1132.
7. Ishikura S, Ohtsu A. Place of radiotherapy and chemoradiotherapy for superficial esophageal carcinoma. In: Yoshimura H et al., editors. Bronchology and Bronchoesophagology: State of the Art. Proceedings of the 11th World Congress for Bronchology (WCB) & the 11th World Congress for Bronchoesophagology (WCBE), held in Yokohama, Japan on the 7th-10th June, 2000, Amsterdam: Elsevier. 2001;193-196.
8. Tanizaki H, Furuse J, Yoshino M, Ogino T, Ishikura S, Satake M, Hasebe T: Combination radiotherapy for hepatocellular carcinoma with intraductal tumor thrombus: a case report. Eur J Radiol 2001;38:213-218.
9. Furuse J, Maru Y, Yoshino M, Mera K, Sumi H, Tajiri H, Satake M, Onaya H, Ishikura S, Ogino T, Kawashima M, Ikeda H. Hepatic arterial infusion of 5-fluorouracil for liver metastases from pancreatic carcinoma: Results from a pilot study. Hepatogastroenterology 2001;48:208-211.
Thoracic Oncology and Surgery Division
1. Ohe Y, Yamamoto S, Suzuki K, Hojo F, Kakinuma R, Matsumoto T, Ohmatsu H, Nishiwaki Y. Risk factors of treatment-related death in chemotherapy and thoracic radiotherapy for lung cancer. Eur J Cancer 2001;37:54-63.
2. Kawasaki H, Nagai K, Yokose T, Yoshida J, Nishimura M, Takahashi K, Suzuki K, Kakinuma R, Nishiwaki Y. Clinicopathological characsteristics of surgically resected lung cancer associated with idiopathic pulmonary fibrosis. J Sur Oncol 2001;76:53-57.
3. Kurata T, Tamura T, Shinkai T, Ohe Y, Kunitoh H, Kodama T, Kakinuma R, Matsumoto T, Kubota K, Ohmatsu H, Nishiwaki Y, Saijo N. Phase I and pharmacological study of paclitaxel given over 3h with cisplatin for advanced non-small cell lung cancer. Jpn J Clin Oncol 2001;31:93-99.
4. Nakahara R, Yokose T, Nagai K, Nishiwaki Y, Ochiai A. Atypical adenomatous hyperplasia of the lung: a clinicopathological study of 118 cases including cases with multiple atypical adnomatous hyperplasia. Thorax 2001;56:302-305.
5. Kawasaki H, Nagai K, Yokose T, Yoshida J, Ohmatsu H, Nishiwaki Y. A 7mm lung adenocarcinoma with mediastinal involvement and lymphangiosis carcinomatosa: A case report. Jpn J Clin Oncol 2001;31:35-38.
6. Kunitoh H, Akiyama Y, Kusaba H, Yamamoto N, Sekine I, Ohe Y, Kubota K, Tamura T, Shinkai T, Kodama T, Goto K, Niho S, Nishiwaki Y, Saijo N. Phase I/II trial of cisplatin, docetaxel and ifosfamide in advanced or recurrent nonsmall cell lung cancer. Lung Cancer 2001;33:259-265.
7. Takamochi K, Nagai K, Yoshida J, Suzuki K, Ohde Y, Nishimura M, Sasaki S, Nishiwaki Y. Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings. J Thorac Cardiovasc Surg 2001;122:325-330.
8. Goto K, Kodama T, Matsuno Y, Yokose T, Asamura H, Kamiya N, Shimosato Y. Cinicopathologic and DNA cytometric analysis of carcinoid tumors of the Thymus. Mod Pathol 2001;14:985-994.
9. Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H. p53 Gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis. Hum Pathol 2001;32:1043-1049.
10. Takamochi K, Ogura T, Suzuki K, Kawasaki H, Kurashima Y, Yokose T, Ochiai A, Nagai K, Nishiwaki Y, Esumi H. Loss of heterozygosity on chromosome 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung. Am J Pathol 2001;159:1941-1948.
11. Goto K, Kodama T, Sekine I, Kakinuma R, Kubota K, Hojo F, Matsumoto T, Ohmatsu H, Ikeda H, Ando M, Nishiwaki Y. Serum levels of KL-6 are useful biomakers for severe radiation pneumonitis. Lung Cancer 2001;34:141-148.
12. Goto K, Yokose T, Kodama T, Nagai K, Nishiwaki Y, Ando M, Mukai K, Ochiai A. Detection of early invasion on the basis of basement membrane destrucyion in small adenocarcinomas of the lung and its Clinical Implications. Mod Pathol 2001;14:1237-1245.
13. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 2002;346: 85-91.
14. Takahashi K, Yoshida J, Nishimura M, Nagai K. Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma. JJTCVS 2001;49:89-93.
15. Ichinose Y, Tsuchiya R, Yasumitsu T, Koike T, Yamamoto Y, Nakagawa K, Tada H, Yokoi K, Nagai K, Kase M. Prognosis of non-small cell lung cancer patients with positive pleural lavage cytology after a thoracotomy: results of the survey conducted by the Japan Clinical Oncology. Lung Canacer 2001;31:37-41.
16. Yonou H, Yokose T, Kamijyo T, Kanomata N, Hasebe T, Nagai K, Hatano T, Ogawa Y, Ochiai A. Establishment of a novel species-and tissue-speciffic metastasis model of human prostate cancer in humanized non-obese diabetic/ servere combined immunodeficient mice engrafted with human adult lung and bone. Cancer Res 2001;61:2177-2182.
17. Suzuki K, Nagai K, Yoshida J, Nishimura M, Nishiwaki Y. Predictors of lymph node and intrapulmonary metastasis in clinical stage IA non-small cell lung carcinoma. Ann Thorac Surg 2001;72:352-356.
18. Funai K, Yokose T, Yoshida J, Nishimura M, Nagai K, Nishiwaki Y, Ochiai A. Thymoma with osseous metaplasia Journal of Computer Assisted Tomography (in press)

Table of Contents